| Literature DB >> 23664862 |
Kishor Kumar Sivaraj1, Mikito Takefuji, Inga Schmidt, Ralf H Adams, Stefan Offermanns, Nina Wettschureck.
Abstract
At sites of angiogenesis, the expression of the key angiogenesis regulator vascular endothelial growth factor (VEGF) and its main receptor, VEGF receptor 2 (VEGFR-2), are strongly upregulated. Whereas the processes controlling VEGF expression are well described, the mechanisms underlying VEGFR-2 upregulation have remained unclear. We found that endothelial VEGFR-2 expression is strongly reduced in the absence of the G protein G13, resulting in an impaired responsiveness to VEGF-A, a phenotype that can be rescued by normalization of VEGFR-2 levels. G13-mediated VEGFR-2 expression involved activation of the small GTPase RhoA and transcription factor NF-κB, the latter acting via a specific binding site at position -84 of the VEGFR-2 promoter. Mice with endothelial cell-specific loss of G13 showed reduced VEGFR-2 expression at sites of angiogenesis and attenuated VEGF effects, resulting in impaired retinal angiogenesis and tumor vascularization. Taken together, we identified G-protein-mediated signaling via G13 as a critical regulator of VEGFR-2 expression during angiogenesis.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23664862 DOI: 10.1016/j.devcel.2013.04.008
Source DB: PubMed Journal: Dev Cell ISSN: 1534-5807 Impact factor: 12.270